Literature DB >> 14739441

The difficulties of testing for SARS.

Albert Cheung Hoi Yu.   

Abstract

Entities:  

Mesh：

Year:  2004        PMID： 14739441     DOI： 10.1126/science.303.5657.469

Source DB:  PubMed          Journal:  Science        ISSN： 0036-8075            Impact factor:   47.728


× No keyword cloud information.
  6 in total

1.  Evaluation of real-time reverse transcriptase PCR and real-time loop-mediated amplification assays for severe acute respiratory syndrome coronavirus detection.

Authors:  Leo L M Poon; Bonnie W Y Wong; Kwok H Chan; Stella S F Ng; Kwok Y Yuen; Yi Guan; J S Malik Peiris
Journal:  J Clin Microbiol       Date:  2005-07       Impact factor: 5.948

Review 2.  Nucleic acid-based diagnostics for infectious diseases in public health affairs.

Authors:  Albert Cheung-Hoi Yu; Greg Vatcher; Xin Yue; Yan Dong; Mao Hua Li; Patrick H K Tam; Parker Y L Tsang; April K Y Wong; Michael H K Hui; Bin Yang; Hao Tang; Lok-Ting Lau
Journal:  Front Med       Date:  2012-06-03       Impact factor: 4.592

Review 3.  The aetiology, origins, and diagnosis of severe acute respiratory syndrome.

Authors:  L L M Poon; Y Guan; J M Nicholls; K Y Yuen; J S M Peiris
Journal:  Lancet Infect Dis       Date:  2004-11       Impact factor: 25.071

4.  Screening laboratory requests.

Authors:  Cathy A Petti; Christopher R Polage; David R Hillyard
Journal:  Emerg Infect Dis       Date:  2006-11       Impact factor: 6.883

5.  Use of clinical criteria and molecular diagnosis to more effectively monitor patients recovering after severe acute respiratory syndrome coronavirus infection.

Authors:  Yin-Wan Wendy Fung; Lok Ting Lau; Freda Pui-Fan Wong; Kin-Wing Choi; Tai-Nin Chau; Sik-To Lai; Chen G Wang; Natalie Dillon; Albert Cheung-Hoi Yu
Journal:  Clin Infect Dis       Date:  2004-08-15       Impact factor: 9.079

6.  Amotosalen photochemical inactivation of severe acute respiratory syndrome coronavirus in human platelet concentrates.

Authors:  D Pinna; A Sampson-Johannes; M Clementi; G Poli; S Rossini; L Lin; E Vicenzi
Journal:  Transfus Med       Date:  2005-08       Impact factor: 2.019
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.